Trials / Conditions / Focal Glomerulosclerosis
Focal Glomerulosclerosis
4 registered clinical trials studyying Focal Glomerulosclerosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis NCT00302536 | Nanjing University School of Medicine | N/A |
| Completed | Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) NCT00193648 | Northwell Health | Phase 1 |
| Completed | Sirolimus for Focal Segmental Glomerulosclerosis NCT00040508 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) NCT00001959 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |